These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8284261)
1. Individual variability in Tyr-Gly-Gly formation from enkephalin hydrolysis in mouse plasma. Schulteis G; Rodriguez WA; Rodriguez SB; Martinez JL Peptides; 1993; 14(5):1083-9. PubMed ID: 8284261 [TBL] [Abstract][Full Text] [Related]
2. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations. Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL Regul Pept; 1991 Feb; 32(3):267-78. PubMed ID: 1678195 [TBL] [Abstract][Full Text] [Related]
3. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan. Hiranuma T; Oka T Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399 [TBL] [Abstract][Full Text] [Related]
4. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides. Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299 [TBL] [Abstract][Full Text] [Related]
5. Enkephalin hydrolysis by mouse plasma in vitro. Shibanoki S; Weinberger SB; Schulteis G; Ishikawa K; Martinez JL Life Sci; 1992; 50(10):667-75. PubMed ID: 1346713 [TBL] [Abstract][Full Text] [Related]
6. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384 [TBL] [Abstract][Full Text] [Related]
7. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localisation and effects of peptidase inhibitors. Llorens-Cortes C; Gros C; Schwartz JC Eur J Pharmacol; 1985 Dec; 119(3):183-91. PubMed ID: 3912194 [TBL] [Abstract][Full Text] [Related]
8. Isolation of a neuropeptide-degrading endopeptidase from the leech Theromyzon tessulatum. Laurent V; Salzet M Eur J Biochem; 1995 Oct; 233(1):186-91. PubMed ID: 7588745 [TBL] [Abstract][Full Text] [Related]
10. The enhancing effects of amastatin, phosphoramidon and captopril on the potency of [Met5]-enkephalin in rat vas deferens. Cui SY; Kajiwara M; Ishii K; Aoki K; Sakamoto J; Matsumiya T; Oka T Jpn J Pharmacol; 1986 Sep; 42(1):43-9. PubMed ID: 3540390 [TBL] [Abstract][Full Text] [Related]
11. The metabolism of neuropeptides. Both phosphoramidon-sensitive and captopril-sensitive metallopeptidases are present in the electric organ of Torpedo marmorata. Turner AJ; Dowdall MJ Biochem J; 1984 Aug; 222(1):255-9. PubMed ID: 6383356 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain. Norman JA; Autry WL; Barbaz BS Mol Pharmacol; 1985 Dec; 28(6):521-6. PubMed ID: 3001497 [TBL] [Abstract][Full Text] [Related]
13. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices. Giros B; Llorens-Cortes C; Gros C; Schwartz JC Peptides; 1986; 7(4):669-77. PubMed ID: 3532054 [TBL] [Abstract][Full Text] [Related]
14. Experience-dependent regulation of Leu-enkephalin hydrolysis in rat plasma. Schulteis G; Martinez JL Peptides; 1993; 14(2):161-7. PubMed ID: 8483796 [TBL] [Abstract][Full Text] [Related]
15. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme. Palenker J; Lentzen H; Brandt U Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331 [TBL] [Abstract][Full Text] [Related]
16. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943 [TBL] [Abstract][Full Text] [Related]
17. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. Song B; Marvizón JC J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189 [TBL] [Abstract][Full Text] [Related]
18. HPLC-ECD determination of the enzymatic hydrolysis of [leu]- and [met]enkephalin in rat plasma. Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL Prog Clin Biol Res; 1990; 328():253-6. PubMed ID: 1968263 [No Abstract] [Full Text] [Related]
19. Antinociceptive effect of [Met5]enkephalin semicarbazide is not affected by dipeptidyl carboxypeptidase-I. Rezaee Z; Arabanian SA; Balalaie S; Ahmadiani A; Khalaj L; Nasoohi S J Pept Sci; 2012 Feb; 18(2):92-6. PubMed ID: 22083687 [TBL] [Abstract][Full Text] [Related]
20. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Aoki K; Kajiwara M; Oka T Jpn J Pharmacol; 1986 Feb; 40(2):297-302. PubMed ID: 3009948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]